Zacks Investment Research on MSN5h
AbbVie's Rinvoq Gets EU Nod for 8th Indication Giant Cell Arteritis
AbbVie ABBV announced that the European Commission has granted marketing approval to its blockbuster drug Rinvoq for treating ...
Zacks Investment Research on MSN5d
FDA Grants Accelerated Approval to NVS Kidney Disease Drug
Novartis NVS obtains FDA approval of atrasentan, a potent and selective endothelin A (ETA) receptor antagonist, for the ...
Medscape5d
Two Oral TYK2 Inhibitors Enter Phase 3 Trials for Plaque Psoriasis on Basis of Phase 2 Promise
Two phase 2 trials with different selective TYK2 inhibitors produce high rates of efficacy in moderate to severe plaque ...